FDA CONFIDENTIALITY CONCERNS PRECLUDE RESPONSES TO INDIVIDUAL PATIENT COMPLAINTS ABOUT DIFFICULTIES RECEIVING UNAPPROVED MEDICATIONS, HHS MAINTAINS

FDA is unable to respond to patient complaints about access to medicines because of confidentiality concerns associated with the sponsors of the specific products in question, HHS maintained in a Sept. 22 letter to Rep. Barton's (R-Tex.) Commerce/Oversight Subcommittee.